Samuel Williams is an accomplished biomedical researcher with extensive experience in product development and leadership roles within prominent biopharmaceutical companies. Currently serving as the Global Product Leader at AstraZeneca since 2025, previous positions include Vice President of Early Product Development at Arsenal Biosciences, Inc., where Samuel led the development of CAR T cell products for solid tumors, and Vice President of Research at TrueBinding, where a multidisciplinary team was built to advance immuno-oncology therapeutics. Notable contributions include leadership in antibody drug conjugate development at AbbVie Stemcentrx and foundational research on HIV latency during postdoctoral fellowships at Gladstone Institutes. Academically, Samuel holds an A.B. in Human Biology from Stanford University and a Ph.D. in Biomedical Sciences from the University of California, San Francisco.
This person is not in the org chart
This person is not in any teams
This person is not in any offices